Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity.

BACKGROUND Telomerase is a ribonucleoprotein enzyme associated with immortalization and transformation of human cells. The telomeric repeat amplification protocol (TRAP) is widely used for the detection of telomerase activity. The TRAP method, although highly sensitive and specific because it includes PCR amplification, is laborious and does not provide precise quantitative information. METHODS We developed a real-time quantitative TRAP (RTQ-TRAP) system by combining a real-time PCR technique with the conventional TRAP method. Telomerase activity in human tumor cell lines and in 13 lymphoma samples was measured using the RTQ-TRAP assay, and the results obtained from the samples using the RTQ-TRAP method were compared with the conventional TRAP method. RESULTS The RTQ-TRAP method was both accurate and reproducible in measuring telomerase activity in a dilution series of protein extracts from HL60 cells. Telomerase activity in 13 lymphoma samples, as determined by the RTQ-TRAP method, was ninefold lower than that measured by the conventional TRAP method. The half-life of telomerase activity in human tumor cells, as determined using RTQ-TRAP, was much shorter than the half-life reported previously. CONCLUSIONS Our results suggest that the conventional TRAP assay frequently overestimates telomerase activity in tumor samples. The RTQ-TRAP method is thus a useful tool to rapidly and precisely quantify telomerase activity.

[1]  G. Roos,et al.  Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. , 1996, Blood.

[2]  J. Mulé,et al.  A rapid and quantitative assay to estimate gene transfer into retrovirally transduced hematopoietic stem/progenitor cells using a 96-well format PCR and fluorescent detection system universal for MMLV-based proviruses. , 1996, Human gene therapy.

[3]  M. Spitz,et al.  Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer , 1999, British Journal of Cancer.

[4]  E. Dmitrovsky,et al.  Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. , 1996, Cancer research.

[5]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[6]  C. Greider,et al.  Telomerase regulation during entry into the cell cycle in normal human T cells. , 1996, Molecular biology of the cell.

[7]  J. Shay,et al.  Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. , 1995, Journal of immunology.

[8]  C. Harley,et al.  Telomerase, cell immortality, and cancer. , 1994, Cold Spring Harbor symposia on quantitative biology.

[9]  A. Sartorelli,et al.  Differentiation of immortal cells inhibits telomerase activity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Weil,et al.  Limitations on the quantitative determination of telomerase activity by the electrophoretic and ELISA based TRAP assays. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[11]  C. R. Connell,et al.  Allelic discrimination by nick-translation PCR with fluorogenic probes. , 1993, Nucleic acids research.

[12]  P. Pisa,et al.  Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia , 1998, British journal of haematology.

[13]  M. Björkholm,et al.  Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms , 1999, British Journal of Cancer.

[14]  R. Badolato,et al.  Molecular and biochemical characterization of JAK3 deficiency in a patient with severe combined immunodeficiency over 20 years after bone marrow transplantation: implications for treatment , 1998, British Journal of Haematology.

[15]  J. Shay,et al.  Regulation of telomerase activity in immortal cell lines , 1996, Molecular and cellular biology.

[16]  K. Riabowol,et al.  Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. , 1996, Cancer research.

[17]  J. Shay,et al.  Lack of cell cycle regulation of telomerase activity in human cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  P. Pisa,et al.  Supression of telomerase activity in HL60 cells after treatment with differentiating agents. , 1996, Leukemia.

[19]  M. Erlanson,et al.  Telomerase activity in Hodgkin's disease. , 1998, Blood.

[20]  Nam W. Kim,et al.  Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP) , 1997, Nucleic Acids Res..

[21]  S. Gallinger,et al.  Telomerase activity associated with acquisition of malignancy in human colorectal cancer. , 1995, Cancer research.